Cited by 51Neuroscience and Neuropharmacology ResearchNeurotransmitter Receptor Influence on BehaviorAmino Acid Enzymes and Metabolism

Astrocytes modulate extracellular neurotransmitter levels and excitatory neurotransmission in dorsolateral striatum via dopamine D2 receptor signaling

Open access
Adermark, Louise, Lagström, Oona, Loftén, Anna, Licheri, Valentina, Havenäng, Amy, Loi, Eleonora Anna, Stomberg, Rosita, Söderpalm, Bo +2 more·2022·Neuropsychopharmacology

Abstract

Astrocytes provide structural and metabolic support of neuronal tissue, but may also be involved in shaping synaptic output. To further define the role of striatal astrocytes in modulating neurotransmission we performed in vivo microdialysis and ex vivo slice electrophysiology combined with metabolic, chemogenetic, and pharmacological approaches. Microdialysis recordings revealed that intrastriatal perfusion of the metabolic uncoupler fluorocitrate (FC) produced a robust increase in extracellular glutamate levels, with a parallel and progressive decline in glutamine. In addition, FC significantly increased the microdialysate concentrations of dopamine and taurine, but did not modulate the extracellular levels of glycine or serine. Despite the increase in glutamate levels, ex vivo electrophysiology demonstrated a reduced excitability of striatal neurons in response to FC. The decrease in evoked potentials was accompanied by an increased paired pulse ratio, and a reduced frequency of spontaneous excitatory postsynaptic currents, suggesting that FC depresses striatal output by reducing the probability of transmitter release. The effect by FC was mimicked by chemogenetic inhibition of astrocytes using G i-coupled designer receptors exclusively activated by designer drugs (DREADDs) targeting GFAP, and by the glial glutamate transporter inhibitor TFB-TBOA. Both FC- and TFB-TBOA-mediated synaptic depression were inhibited in brain slices pre-treated with the dopamine D2 receptor antagonist sulpiride, but insensitive to agents acting on presynaptic glutamatergic autoreceptors, NMDA receptors, gap junction coupling, cannabinoid 1 receptors, µ-opioid receptors, P2 receptors or GABA A receptors. In conclusion, our data collectively support a role for astrocytes in modulating striatal neurotransmission and suggest that reduced transmission after astrocytic inhibition involves dopamine.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41386-021-01232-x

Cites

86 of 86 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • An increase in DA signaling brought on by compromised astrocyte activity may induce a long-lasting change in striatal neurotransmission since DA signaling is crucial for both structural and synaptic plasticity.

    “An increase in DA signaling brought on by compromised astrocyte activity may induce a long-lasting change in striatal neurotransmission 80 since DA signaling is crucial for both structural and synaptic plasticity. 82”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. Fonnum F, Johnsen A, Hassel B. Use of fluorocitrate and fluoroacetate in the study of brain metabolism. Glia 1997;21:106-13.

Cited by

Sorted by citations

Authors
Adermark, L., Lagström, O., Loftén, A., Licheri, V., Havenäng, A., Loi, E. A., Stomberg, R., Söderpalm, B., Domi, A., & Ericson, M.
Affiliations
  • University of Gothenburg (SE)
  • Sahlgrenska University Hospital (SE)
Corresponding author
Adermark, Louise
Venue
Neuropsychopharmacology
Published
2021-11-22
Volume
47
Issue
8
Pages
1493-1502
ISSN
  • 0893-133X (ISSN-L)
  • 1740-634X
OpenAlex
W3215653006
Cited by
51
References
86
Citations by year
2026: 14 · 2025: 9 · 2024: 18 · 2023: 6 · 2022: 3
FWCI
3.11
Type
journal article
Language
en
Open access
Locations
  • Neuropsychopharmacology (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
Vetenskapsrådet (2018‐02814, 2020-01346, 2020-02105)
Topics
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Amino Acid Enzymes and Metabolism
Keywords
astrocytes, dorsolateral striatum, dopamine D2 receptor, excitatory neurotransmission, extracellular glutamate, fluorocitrate, synaptic depression, neurotransmitter release probability, glial fibrillary acidic protein, sulpiride, astrocyte-neuron interaction, glutamate transporters
MeSH terms
Astrocytes, Dopamine, Synaptic Transmission, Receptors, Dopamine D2, Glutamic Acid, Dopamine D2 Receptor Antagonists

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review